The award was presented following the conference’s pitch competition, highlighting Neumirna’s innovative RNA-based approach to treating neurological diseases and its strong promise in the biotech space.
Neumirna Wins Nordic Star Award at NLS Days 2023
Neumirna has been awarded the Nordic Star Award at NLS Days 2023, recognizing the company as the start-up with the highest investment potential.
.png)
.svg)